Dec 12, 2020RecruitingNCT04405167: Phase 1: Tasquinimod for the Treatment of Relapsed or Refractory MyelomaNCT04405167: Phase 1: Tasquinimod for the Treatment of Relapsed or Refractory Myeloma NCT04405167: Phase 1: Tasquinimod for the Treatment...